TY  - JOUR
AU  - Fincke, Victoria E
AU  - Steinbügl, Mona
AU  - Chun, Hye-Jung E
AU  - Nemes, Karolina
AU  - Mucha, Marlena
AU  - Loßner, Maurice
AU  - Dorn, Felix
AU  - Gastberger, Katharina
AU  - Bühner, Sebastian
AU  - Sill, Martin
AU  - Kröncke, Thomas
AU  - Siebert, Reiner
AU  - Melchior, Patrick
AU  - Furtwängler, Rhoikos
AU  - Schlesner, Matthias
AU  - Vokuhl, Christian
AU  - Röcken, Christoph
AU  - Johann, Pascal
AU  - Frühwald, Michael C
TI  - Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors.
JO  - Clinical cancer research
VL  - 30
IS  - 20
SN  - 1078-0432
CY  - Philadelphia, Pa. [u.a.]
PB  - AACR
M1  - DKFZ-2024-02063
SP  - 4667 - 4680
PY  - 2024
N1  - #LA:B062#
AB  - Extracranial malignant rhabdoid tumors (eMRT) are a challenging entity. Despite the use of multimodal treatment approaches, therapy failure occurs in 55
KW  - Humans
KW  - Rhabdoid Tumor: genetics
KW  - Rhabdoid Tumor: pathology
KW  - Rhabdoid Tumor: therapy
KW  - Male
KW  - Female
KW  - Risk Factors
KW  - Child, Preschool
KW  - Biomarkers, Tumor: genetics
KW  - Infant
KW  - Child
KW  - Prognosis
KW  - DNA Methylation
KW  - Neoplasm Recurrence, Local: genetics
KW  - Neoplasm Recurrence, Local: pathology
KW  - Adolescent
KW  - Transcriptome
KW  - Gene Expression Profiling
KW  - Biomarkers, Tumor (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:39120581
DO  - DOI:10.1158/1078-0432.CCR-23-3489
UR  - https://inrepo02.dkfz.de/record/294035
ER  -